共 20 条
[11]
Supkero, Krauss, Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management, Circulation, 90, pp. 1056-1069, (1994)
[12]
Giles, Anda, Jones, Serdula, Merritt, DeStefano, Recent trends in the identification and treatment of high blood cholesterol by physicians, JAMA, 269, pp. 1133-1138, (1993)
[13]
DeBusk, Miller, Superko, Dennis, Thomas, Lew, Berger, Heller, Rompf, Gee, Kraemer, Bandura, Ghandour, Clark, Shah, Fisher, Taylor, A case-management system for coronary risk factor modification after acute myocardial infarction, Ann Intern Med, 120, pp. 721-729, (1994)
[14]
Cohen, Byrne, Levine, Gutowski, Adelson, Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease, Circulation, 83, pp. 1294-1304, (1991)
[15]
Superko, Desmond, de Santos, Vranizan, Farquhar, Blood cholesterol treatment attitudes of community physicians: a major problem, Am Heart J, 116, pp. 849-855, (1988)
[16]
Roberts, Getting cardiologists interested in lipids, Am J Cardiol, 72, pp. 744-745, (1993)
[17]
Campeau, Coronary risk factors and the post bypass patient, Cardiovascular Clinics, pp. 123-133, (1991)
[18]
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet, 344, pp. 1383-1389, (1994)
[19]
Blankenhorn, Nessim, Johnson, Sanmarco, Azen, Cashin-Hemphill, Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts, JAMA, 257, pp. 3233-3240, (1987)
[20]
Stewart, Brown, Zhao, Hilliger, Sniderman, Dowdy, Fisher, Albers, Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol, Journal of the American College of Cardiology, 23, pp. 899-906, (1994)